Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-01

Clinical Trial Update: PanACEA Sutezolid Dose-finding and Combination Evaluation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dose-finding and combination strategies for sutezolid in pulmonary tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PanACEA
  • sutezolid (sutezolid)

Snippet

Sponsor: Michael Hoelscher | Conditions: Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED